APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blood Plasma Fractionation

Compare research editions
View pricing & licenses

Selected research

Industry Research

Blood Plasma Fractionation Industry Research Report 2026

Report ID 173898940519 December 2025135 pages

Choose your research edition.

Industry ResearchBlood Plasma Fractionation Industry Research Report 2026135 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Plasma Fractionation Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Blood Plasma Fractionation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Plasma Fractionation Market Outlook and Growth Opportunities 2026201 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Plasma Fractionation Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Blood Plasma Fractionation market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Blood Plasma Fractionation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Blood Plasma Fractionation is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Blood Plasma Fractionation is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Blood Plasma Fractionation include Takeda, CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Blood Plasma Fractionation market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Blood Plasma Fractionation Market by Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Blood Plasma Fractionation Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Others

Blood Plasma Fractionation Segment by Application

Hospital

Retail Pharmacy

Others

Blood Plasma Fractionation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Plasma Fractionation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Plasma Fractionation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Plasma Fractionation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Blood Plasma Fractionation manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Blood Plasma Fractionation by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Blood Plasma Fractionation in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Blood Plasma Fractionation Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Blood Plasma Fractionation Sales Market Share by Manufacturers (2021-2026) Table 8. Global Blood Plasma Fractionation Revenue of Manufacturers (2021-2026) Table 9. Global Blood Plasma Fractionation Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Blood Plasma Fractionation Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Blood Plasma Fractionation Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Blood Plasma Fractionation, Product Type & Application Table 14. Global Blood Plasma Fractionation Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Blood Plasma Fractionation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Takeda Company Information Table 19. Takeda Business Overview Table 20. Takeda Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Takeda Blood Plasma Fractionation Product Portfolio Table 22. Takeda Recent Developments Table 23. CSL Company Information Table 24. CSL Business Overview Table 25. CSL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. CSL Blood Plasma Fractionation Product Portfolio Table 27. CSL Recent Developments Table 28. Grifols Company Information Table 29. Grifols Business Overview Table 30. Grifols Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Grifols Blood Plasma Fractionation Product Portfolio Table 32. Grifols Recent Developments Table 33. Octapharma Company Information Table 34. Octapharma Business Overview Table 35. Octapharma Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Octapharma Blood Plasma Fractionation Product Portfolio Table 37. Octapharma Recent Developments Table 38. Kedrion Company Information Table 39. Kedrion Business Overview Table 40. Kedrion Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Kedrion Blood Plasma Fractionation Product Portfolio Table 42. Kedrion Recent Developments Table 43. LFB Group Company Information Table 44. LFB Group Business Overview Table 45. LFB Group Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. LFB Group Blood Plasma Fractionation Product Portfolio Table 47. LFB Group Recent Developments Table 48. Biotest Company Information Table 49. Biotest Business Overview Table 50. Biotest Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Biotest Blood Plasma Fractionation Product Portfolio Table 52. Biotest Recent Developments Table 53. BPL Company Information Table 54. BPL Business Overview Table 55. BPL Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. BPL Blood Plasma Fractionation Product Portfolio Table 57. BPL Recent Developments Table 58. RAAS Company Information Table 59. RAAS Business Overview Table 60. RAAS Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. RAAS Blood Plasma Fractionation Product Portfolio Table 62. RAAS Recent Developments Table 63. CBPO Company Information Table 64. CBPO Business Overview Table 65. CBPO Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. CBPO Blood Plasma Fractionation Product Portfolio Table 67. CBPO Recent Developments Table 68. Hualan Bio Company Information Table 69. Hualan Bio Business Overview Table 70. Hualan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hualan Bio Blood Plasma Fractionation Product Portfolio Table 72. Hualan Bio Recent Developments Table 73. Tiantan Bio Company Information Table 74. Tiantan Bio Business Overview Table 75. Tiantan Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Tiantan Bio Blood Plasma Fractionation Product Portfolio Table 77. Tiantan Bio Recent Developments Table 78. Shuanglin Bio Company Information Table 79. Shuanglin Bio Business Overview Table 80. Shuanglin Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Shuanglin Bio Blood Plasma Fractionation Product Portfolio Table 82. Shuanglin Bio Recent Developments Table 83. Boya Bio Company Information Table 84. Boya Bio Business Overview Table 85. Boya Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Boya Bio Blood Plasma Fractionation Product Portfolio Table 87. Boya Bio Recent Developments Table 88. Yuanda Shuyang Company Information Table 89. Yuanda Shuyang Business Overview Table 90. Yuanda Shuyang Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Yuanda Shuyang Blood Plasma Fractionation Product Portfolio Table 92. Yuanda Shuyang Recent Developments Table 93. Weiguang Bio Company Information Table 94. Weiguang Bio Business Overview Table 95. Weiguang Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Weiguang Bio Blood Plasma Fractionation Product Portfolio Table 97. Weiguang Bio Recent Developments Table 98. Nanyue Bio Company Information Table 99. Nanyue Bio Business Overview Table 100. Nanyue Bio Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Nanyue Bio Blood Plasma Fractionation Product Portfolio Table 102. Nanyue Bio Recent Developments Table 103. KM Biologics Company Information Table 104. KM Biologics Business Overview Table 105. KM Biologics Blood Plasma Fractionation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. KM Biologics Blood Plasma Fractionation Product Portfolio Table 107. KM Biologics Recent Developments Table 108. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 109. Global Blood Plasma Fractionation Sales by Region (2021-2026) & (K Units) Table 110. Global Blood Plasma Fractionation Sales Market Share by Region (2021-2026) Table 111. Global Blood Plasma Fractionation Sales by Region (2027-2032) & (K Units) Table 112. Global Blood Plasma Fractionation Sales Market Share by Region (2027-2032) Table 113. Global Blood Plasma Fractionation Revenue by Region (2021-2026) & (US$ Million) Table 114. Global Blood Plasma Fractionation Revenue Market Share by Region (2021-2026) Table 115. Global Blood Plasma Fractionation Revenue by Region (2027-2032) & (US$ Million) Table 116. Global Blood Plasma Fractionation Revenue Market Share by Region (2027-2032) Table 117. North America Blood Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. North America Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 119. North America Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 120. North America Blood Plasma Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 121. North America Blood Plasma Fractionation Revenue by Country (2027-2032) & (US$ Million) Table 122. Europe Blood Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Europe Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 124. Europe Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 125. Europe Blood Plasma Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 126. Europe Blood Plasma Fractionation Revenue by Country (2027-2032) & (US$ Million) Table 127. Asia Pacific Blood Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. Asia Pacific Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 129. Asia Pacific Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 130. Asia Pacific Blood Plasma Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 131. Asia Pacific Blood Plasma Fractionation Revenue by Country (2027-2032) & (US$ Million) Table 132. South America Blood Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. South America Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 134. South America Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 135. South America Blood Plasma Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 136. South America Blood Plasma Fractionation Revenue by Country (2027-2032) & (US$ Million) Table 137. Middle East and Africa Blood Plasma Fractionation Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Middle East and Africa Blood Plasma Fractionation Sales by Country (2021-2026) & (K Units) Table 139. Middle East and Africa Blood Plasma Fractionation Sales by Country (2027-2032) & (K Units) Table 140. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2021-2026) & (US$ Million) Table 141. Middle East and Africa Blood Plasma Fractionation Revenue by Country (2027-2032) & (US$ Million) Table 142. Global Blood Plasma Fractionation Sales by Type (2021-2026) & (K Units) Table 143. Global Blood Plasma Fractionation Sales by Type (2027-2032) & (K Units) Table 144. Global Blood Plasma Fractionation Sales Market Share by Type (2021-2026) Table 145. Global Blood Plasma Fractionation Sales Market Share by Type (2027-2032) Table 146. Global Blood Plasma Fractionation Revenue by Type (2021-2026) & (US$ Million) Table 147. Global Blood Plasma Fractionation Revenue by Type (2027-2032) & (US$ Million) Table 148. Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2026) Table 149. Global Blood Plasma Fractionation Revenue Market Share by Type (2027-2032) Table 150. Global Blood Plasma Fractionation Price by Type (2021-2026) & (US$/Unit) Table 151. Global Blood Plasma Fractionation Price by Type (2027-2032) & (US$/Unit) Table 152. Global Blood Plasma Fractionation Sales by Application (2021-2026) & (K Units) Table 153. Global Blood Plasma Fractionation Sales by Application (2027-2032) & (K Units) Table 154. Global Blood Plasma Fractionation Sales Market Share by Application (2021-2026) Table 155. Global Blood Plasma Fractionation Sales Market Share by Application (2027-2032) Table 156. Global Blood Plasma Fractionation Revenue by Application (2021-2026) & (US$ Million) Table 157. Global Blood Plasma Fractionation Revenue by Application (2027-2032) & (US$ Million) Table 158. Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2026) Table 159. Global Blood Plasma Fractionation Revenue Market Share by Application (2027-2032) Table 160. Global Blood Plasma Fractionation Price by Application (2021-2026) & (US$/Unit) Table 161. Global Blood Plasma Fractionation Price by Application (2027-2032) & (US$/Unit) Table 162. Key Raw Materials Table 163. Raw Materials Key Suppliers Table 164. Blood Plasma Fractionation Distributors List Table 165. Blood Plasma Fractionation Customers List Table 166. Blood Plasma Fractionation Industry Trends Table 167. Blood Plasma Fractionation Industry Drivers Table 168. Blood Plasma Fractionation Industry Restraints Table 169. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Blood Plasma Fractionation Product Image Figure 5. Global Blood Plasma Fractionation Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Blood Plasma Fractionation Market Size (2021-2032) & (US$ Million) Figure 7. Global Blood Plasma Fractionation Sales (2021-2032) & (K Units) Figure 8. Global Blood Plasma Fractionation Average Price (US$/Unit) & (2021-2032) Figure 9. Immune Globulin Product Image Figure 10. Coagulation Factor Product Image Figure 11. Albumin Product Image Figure 12. Others Product Image Figure 13. Hospital Product Image Figure 14. Retail Pharmacy Product Image Figure 15. Others Product Image Figure 16. Global Blood Plasma Fractionation Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Blood Plasma Fractionation Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Blood Plasma Fractionation Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Blood Plasma Fractionation Sales by Region in 2025 Figure 22. Global Blood Plasma Fractionation Revenue by Region in 2025 Figure 23. North America Blood Plasma Fractionation Market Size by Country in 2025 Figure 24. North America Blood Plasma Fractionation Sales Market Share by Country (2021-2032) Figure 25. North America Blood Plasma Fractionation Revenue Market Share by Country (2021-2032) Figure 26. United States Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Blood Plasma Fractionation Market Size by Country in 2025 Figure 30. Europe Blood Plasma Fractionation Sales Market Share by Country (2021-2032) Figure 31. Europe Blood Plasma Fractionation Revenue Market Share by Country (2021-2032) Figure 32. Germany Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Blood Plasma Fractionation Market Size by Country in 2025 Figure 43. Asia Pacific Blood Plasma Fractionation Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Blood Plasma Fractionation Revenue Market Share by Country (2021-2032) Figure 45. China Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Blood Plasma Fractionation Market Size by Country in 2025 Figure 54. South America Blood Plasma Fractionation Sales Market Share by Country (2021-2032) Figure 55. South America Blood Plasma Fractionation Revenue Market Share by Country (2021-2032) Figure 56. Brazil Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Blood Plasma Fractionation Market Size by Country in 2025 Figure 60. Middle East and Africa Blood Plasma Fractionation Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Blood Plasma Fractionation Revenue Market Share by Country (2021-2032) Figure 62. Egypt Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Blood Plasma Fractionation Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Blood Plasma Fractionation Sales Market Share by Type (2021-2032) Figure 68. Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2032) Figure 69. Global Blood Plasma Fractionation Price (US$/Unit) by Type (2021-2032) Figure 70. Global Blood Plasma Fractionation Sales Market Share by Application (2021-2032) Figure 71. Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2032) Figure 72. Global Blood Plasma Fractionation Price (US$/Unit) by Application (2021-2032) Figure 73. Blood Plasma Fractionation Value Chain Figure 74. Blood Plasma Fractionation Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Blood Plasma Fractionation Industry Opportunities and Challenges

Scope & coverage.

Types
  • Immune Globulin
  • Coagulation Factor
  • Albumin
  • Others
Applications
  • Hospital
  • Retail Pharmacy
  • Others
Companies covered
  • Takeda
  • CSL
  • Grifols
  • Octapharma
  • Kedrion
  • LFB Group
  • Biotest
  • BPL
  • RAAS
  • CBPO
  • Hualan Bio
  • Tiantan Bio
  • Shuanglin Bio
  • Boya Bio
  • Yuanda Shuyang
  • Weiguang Bio
  • Nanyue Bio
  • KM Biologics

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Blood Plasma Fractionation Market Size (2021-2032)
  4. 2.2.2 Global Blood Plasma Fractionation Sales (2021-2032)
  5. 2.2.3 Global Blood Plasma Fractionation Market Average Price (2021-2032)
  6. 2.3 Blood Plasma Fractionation by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Immune Globulin
  9. 2.3.3 Coagulation Factor
  10. 2.3.4 Albumin
  11. 2.3.5 Others
  12. 2.4 Blood Plasma Fractionation by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Hospital
  15. 2.4.3 Retail Pharmacy
  16. 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Blood Plasma Fractionation Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Blood Plasma Fractionation Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Blood Plasma Fractionation Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Blood Plasma Fractionation Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Blood Plasma Fractionation Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Blood Plasma Fractionation, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Blood Plasma Fractionation, Product Type & Application
  8. 3.8 Global Manufacturers of Blood Plasma Fractionation, Established Date
  9. 3.9 Global Blood Plasma Fractionation Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Takeda
  2. 4.1.1 Takeda Company Information
  3. 4.1.2 Takeda Business Overview
  4. 4.1.3 Takeda Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Takeda Blood Plasma Fractionation Product Portfolio
  6. 4.1.5 Takeda Recent Developments
  7. 4.2 CSL
  8. 4.2.1 CSL Company Information
  9. 4.2.2 CSL Business Overview
  10. 4.2.3 CSL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 CSL Blood Plasma Fractionation Product Portfolio
  12. 4.2.5 CSL Recent Developments
  13. 4.3 Grifols
  14. 4.3.1 Grifols Company Information
  15. 4.3.2 Grifols Business Overview
  16. 4.3.3 Grifols Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Grifols Blood Plasma Fractionation Product Portfolio
  18. 4.3.5 Grifols Recent Developments
  19. 4.4 Octapharma
  20. 4.4.1 Octapharma Company Information
  21. 4.4.2 Octapharma Business Overview
  22. 4.4.3 Octapharma Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Octapharma Blood Plasma Fractionation Product Portfolio
  24. 4.4.5 Octapharma Recent Developments
  25. 4.5 Kedrion
  26. 4.5.1 Kedrion Company Information
  27. 4.5.2 Kedrion Business Overview
  28. 4.5.3 Kedrion Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Kedrion Blood Plasma Fractionation Product Portfolio
  30. 4.5.5 Kedrion Recent Developments
  31. 4.6 LFB Group
  32. 4.6.1 LFB Group Company Information
  33. 4.6.2 LFB Group Business Overview
  34. 4.6.3 LFB Group Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 LFB Group Blood Plasma Fractionation Product Portfolio
  36. 4.6.5 LFB Group Recent Developments
  37. 4.7 Biotest
  38. 4.7.1 Biotest Company Information
  39. 4.7.2 Biotest Business Overview
  40. 4.7.3 Biotest Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Biotest Blood Plasma Fractionation Product Portfolio
  42. 4.7.5 Biotest Recent Developments
  43. 4.8 BPL
  44. 4.8.1 BPL Company Information
  45. 4.8.2 BPL Business Overview
  46. 4.8.3 BPL Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 BPL Blood Plasma Fractionation Product Portfolio
  48. 4.8.5 BPL Recent Developments
  49. 4.9 RAAS
  50. 4.9.1 RAAS Company Information
  51. 4.9.2 RAAS Business Overview
  52. 4.9.3 RAAS Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 RAAS Blood Plasma Fractionation Product Portfolio
  54. 4.9.5 RAAS Recent Developments
  55. 4.10 CBPO
  56. 4.10.1 CBPO Company Information
  57. 4.10.2 CBPO Business Overview
  58. 4.10.3 CBPO Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 CBPO Blood Plasma Fractionation Product Portfolio
  60. 4.10.5 CBPO Recent Developments
  61. 4.11 Hualan Bio
  62. 4.11.1 Hualan Bio Company Information
  63. 4.11.2 Hualan Bio Business Overview
  64. 4.11.3 Hualan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Hualan Bio Blood Plasma Fractionation Product Portfolio
  66. 4.11.5 Hualan Bio Recent Developments
  67. 4.12 Tiantan Bio
  68. 4.12.1 Tiantan Bio Company Information
  69. 4.12.2 Tiantan Bio Business Overview
  70. 4.12.3 Tiantan Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Tiantan Bio Blood Plasma Fractionation Product Portfolio
  72. 4.12.5 Tiantan Bio Recent Developments
  73. 4.13 Shuanglin Bio
  74. 4.13.1 Shuanglin Bio Company Information
  75. 4.13.2 Shuanglin Bio Business Overview
  76. 4.13.3 Shuanglin Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Shuanglin Bio Blood Plasma Fractionation Product Portfolio
  78. 4.13.5 Shuanglin Bio Recent Developments
  79. 4.14 Boya Bio
  80. 4.14.1 Boya Bio Company Information
  81. 4.14.2 Boya Bio Business Overview
  82. 4.14.3 Boya Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Boya Bio Blood Plasma Fractionation Product Portfolio
  84. 4.14.5 Boya Bio Recent Developments
  85. 4.15 Yuanda Shuyang
  86. 4.15.1 Yuanda Shuyang Company Information
  87. 4.15.2 Yuanda Shuyang Business Overview
  88. 4.15.3 Yuanda Shuyang Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Yuanda Shuyang Blood Plasma Fractionation Product Portfolio
  90. 4.15.5 Yuanda Shuyang Recent Developments
  91. 4.16 Weiguang Bio
  92. 4.16.1 Weiguang Bio Company Information
  93. 4.16.2 Weiguang Bio Business Overview
  94. 4.16.3 Weiguang Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Weiguang Bio Blood Plasma Fractionation Product Portfolio
  96. 4.16.5 Weiguang Bio Recent Developments
  97. 4.17 Nanyue Bio
  98. 4.17.1 Nanyue Bio Company Information
  99. 4.17.2 Nanyue Bio Business Overview
  100. 4.17.3 Nanyue Bio Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Nanyue Bio Blood Plasma Fractionation Product Portfolio
  102. 4.17.5 Nanyue Bio Recent Developments
  103. 4.18 KM Biologics
  104. 4.18.1 KM Biologics Company Information
  105. 4.18.2 KM Biologics Business Overview
  106. 4.18.3 KM Biologics Blood Plasma Fractionation Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 KM Biologics Blood Plasma Fractionation Product Portfolio
  108. 4.18.5 KM Biologics Recent Developments
5 Global Blood Plasma Fractionation Market Scenario by Region
  1. 5.1 Global Blood Plasma Fractionation Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Blood Plasma Fractionation Sales by Region: 2021-2032
  3. 5.2.1 Global Blood Plasma Fractionation Sales by Region: 2021-2026
  4. 5.2.2 Global Blood Plasma Fractionation Sales by Region: 2027-2032
  5. 5.3 Global Blood Plasma Fractionation Revenue by Region: 2021-2032
  6. 5.3.1 Global Blood Plasma Fractionation Revenue by Region: 2021-2026
  7. 5.3.2 Global Blood Plasma Fractionation Revenue by Region: 2027-2032
  8. 5.4 North America Blood Plasma Fractionation Market Facts & Figures by Country
  9. 5.4.1 North America Blood Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Blood Plasma Fractionation Sales by Country (2021-2032)
  11. 5.4.3 North America Blood Plasma Fractionation Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Blood Plasma Fractionation Market Facts & Figures by Country
  16. 5.5.1 Europe Blood Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Blood Plasma Fractionation Sales by Country (2021-2032)
  18. 5.5.3 Europe Blood Plasma Fractionation Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Blood Plasma Fractionation Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Blood Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Blood Plasma Fractionation Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Blood Plasma Fractionation Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Blood Plasma Fractionation Market Facts & Figures by Country
  41. 5.7.1 South America Blood Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Blood Plasma Fractionation Sales by Country (2021-2032)
  43. 5.7.3 South America Blood Plasma Fractionation Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Blood Plasma Fractionation Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Blood Plasma Fractionation Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Blood Plasma Fractionation Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Blood Plasma Fractionation Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Blood Plasma Fractionation Sales by Type (2021-2032)
  2. 6.1.1 Global Blood Plasma Fractionation Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Blood Plasma Fractionation Sales Market Share by Type (2021-2032)
  4. 6.2 Global Blood Plasma Fractionation Revenue by Type (2021-2032)
  5. 6.2.1 Global Blood Plasma Fractionation Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Blood Plasma Fractionation Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Blood Plasma Fractionation Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Blood Plasma Fractionation Sales by Application (2021-2032)
  2. 7.1.1 Global Blood Plasma Fractionation Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Blood Plasma Fractionation Sales Market Share by Application (2021-2032)
  4. 7.2 Global Blood Plasma Fractionation Revenue by Application (2021-2032)
  5. 7.2.1 Global Blood Plasma Fractionation Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Blood Plasma Fractionation Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Blood Plasma Fractionation Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Blood Plasma Fractionation Value Chain Analysis
  2. 8.1.1 Blood Plasma Fractionation Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Blood Plasma Fractionation Production Mode & Process
  5. 8.2 Blood Plasma Fractionation Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Blood Plasma Fractionation Distributors
  8. 8.2.3 Blood Plasma Fractionation Customers
9 Global Blood Plasma Fractionation Analyzing Market Dynamics
  1. 9.1 Blood Plasma Fractionation Industry Trends
  2. 9.2 Blood Plasma Fractionation Industry Drivers
  3. 9.3 Blood Plasma Fractionation Industry Opportunities and Challenges
  4. 9.4 Blood Plasma Fractionation Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst